The pharmaceutical community is excited by retatrutide, a innovative dual GIP and GLP-1 agonist that’s showing impressive results in early trials . This treatment works by mimicking natural hormones to regulate appetite and increase feelings of satisfaction , ultimately resulting in substantial w